SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead pro...
Q1 2026
May 12, 2026
FY 2025
Mar 9, 2026
Q4 2025
Q3 2025
Nov 14, 2025
Q2 2025
Aug 7, 2025